Stock AMBEY AMBEY LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ambey Laboratories Limited

Equities

AMBEY

INE0M3I01029

Delayed NSE India S.E.
Other stock markets
 09:31:22 16/07/2024 BST 		5-day change 1st Jan Change
87.8 INR -4.98% Intraday chart for Ambey Laboratories Limited 0.00% 0.00%
07-09 Ambey Laboratories Limited has completed an IPO in the amount of INR 446.76 million. CI

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023
Net sales 1 670.4 819.7 849.1 1,074
EBITDA 1 53.67 100.8 108 107.1
EBIT 1 30.13 68.53 78.29 79.93
Operating Margin 4.49% 8.36% 9.22% 7.44%
Earnings before Tax (EBT) 1 3.208 28.02 49.75 62.19
Net income 1 2.16 29.15 55.33 45.69
Net margin 0.32% 3.56% 6.52% 4.26%
EPS 2 0.4410 5.956 3.117 2.574
Free Cash Flow - - - 27.59
FCF margin - - - 2.57%
FCF Conversion (EBITDA) - - - 25.76%
FCF Conversion (Net income) - - - 60.39%
Dividend per Share - - - -
Announcement Date 02/09/21 02/09/21 12/09/22 05/02/24
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023
Net Debt 1 344 327 182 126
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 6.401 x 3.248 x 1.689 x 1.18 x
Free Cash Flow - - - 27.6
ROE (net income / shareholders' equity) - -17.9% -1,238% 21.4%
ROA (Net income/ Total Assets) - 10.8% 11.1% 8.8%
Assets 1 - 270.3 497.7 519.3
Book Value Per Share 2 -36.20 -30.20 7.830 13.30
Cash Flow per Share 2 0.8700 1.040 0.1500 0.2300
Capex - - - 30.9
Capex / Sales - - - 2.88%
Announcement Date 02/09/21 02/09/21 12/09/22 05/02/24
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. AMBEY Stock
  4. Financials Ambey Laboratories Limited